Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG)

Matikas, A.; Kentepozidis, Ν.; Ardavanis, A.; Vaslamatzis, M.; Polyzos, A.; Emmanouilides, Ch.; Katsaounis, P.; Koinis, F.; Xynogalos, S.; Christopoulou, A.; Ziras, N.; Tegos, Th.; Prinarakis, E.; Hatzidaki, D.; Georgoulias, V.; Kotsakis, A.

期刊名称Cancer Chemotherapy and Pharmacology
作者Matikas, A.; Kentepozidis, Ν.; Ardavanis, A.; Vaslamatzis, M.; Polyzos, A.; Emmanouilides, Ch.; Katsaounis, P.; Koinis, F.; Xynogalos, S.; Christopoulou, A.; Ziras, N.; Tegos, Th.; Prinarakis, E.; Hatzidaki, D.; Georgoulias, V.; Kotsakis, A.
卷第78卷
期第2期
印刷ISSN0344-5704
电子ISSN1432-0843
文件大小701.22KB
发表时间2016-8-22
DOI10.1007/s00280-016-3094-7
页码369-376

发现好书期刊，享受阅读乐趣

Efficacy and tolerance of frontline bevacizumab-based chemotherapy for advanced non-small cell lung cancer patients: a multicenter, phase IV study of the Hellenic Oncology Research Group (HORG)